Achillion Pharmaceuticals, Inc. President and CEO to Ring The NASDAQ Stock Market Opening Bell
ADVISORY, Oct. 25, 2011 (GLOBE NEWSWIRE) -- What: Achillion Pharmaceuticals, Inc. (ACHN), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, will visit the NASDAQ MarketSite in New York City's Times Square to celebrate its 5th anniversary as a NASDAQ-listed company.